Current status and future of antifungal therapy for systemic mycoses.

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Since the 1950s there has been an increase in the incidence of invasive fungal disease. The first successful systemically administered antifungal drug, amphotericin B, was introduced in the 1950s and, until very recently, was considered the best therapeutic drug for severe mycoses. The development of new antifungals to treat systemic disease has been slow compared to that of antibacterial compounds, with the introduction of only a single new class of drugs over the past 20 years. This review discusses the antifungal drugs that are clinically in use and summarizes interesting new applications and patents from the US Patent and Trademark Office.

Original languageEnglish (US)
Pages (from-to)75-84
Number of pages10
JournalRecent Patents on Anti-Infective Drug Discovery
Volume1
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Mycoses
Patents
Pharmaceutical Preparations
Amphotericin B
Therapeutics
Incidence

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Drug Discovery

Cite this

Current status and future of antifungal therapy for systemic mycoses. / Nosanchuk, Joshua D.

In: Recent Patents on Anti-Infective Drug Discovery, Vol. 1, No. 1, 01.2006, p. 75-84.

Research output: Contribution to journalArticle

@article{d26702c4ccdb4b1ba727b5af4f21c6d3,
title = "Current status and future of antifungal therapy for systemic mycoses.",
abstract = "Since the 1950s there has been an increase in the incidence of invasive fungal disease. The first successful systemically administered antifungal drug, amphotericin B, was introduced in the 1950s and, until very recently, was considered the best therapeutic drug for severe mycoses. The development of new antifungals to treat systemic disease has been slow compared to that of antibacterial compounds, with the introduction of only a single new class of drugs over the past 20 years. This review discusses the antifungal drugs that are clinically in use and summarizes interesting new applications and patents from the US Patent and Trademark Office.",
author = "Nosanchuk, {Joshua D.}",
year = "2006",
month = "1",
doi = "10.2174/157489106775244109",
language = "English (US)",
volume = "1",
pages = "75--84",
journal = "Recent Patents on Anti-Infective Drug Discovery",
issn = "1574-891X",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Current status and future of antifungal therapy for systemic mycoses.

AU - Nosanchuk, Joshua D.

PY - 2006/1

Y1 - 2006/1

N2 - Since the 1950s there has been an increase in the incidence of invasive fungal disease. The first successful systemically administered antifungal drug, amphotericin B, was introduced in the 1950s and, until very recently, was considered the best therapeutic drug for severe mycoses. The development of new antifungals to treat systemic disease has been slow compared to that of antibacterial compounds, with the introduction of only a single new class of drugs over the past 20 years. This review discusses the antifungal drugs that are clinically in use and summarizes interesting new applications and patents from the US Patent and Trademark Office.

AB - Since the 1950s there has been an increase in the incidence of invasive fungal disease. The first successful systemically administered antifungal drug, amphotericin B, was introduced in the 1950s and, until very recently, was considered the best therapeutic drug for severe mycoses. The development of new antifungals to treat systemic disease has been slow compared to that of antibacterial compounds, with the introduction of only a single new class of drugs over the past 20 years. This review discusses the antifungal drugs that are clinically in use and summarizes interesting new applications and patents from the US Patent and Trademark Office.

UR - http://www.scopus.com/inward/record.url?scp=33748933537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748933537&partnerID=8YFLogxK

U2 - 10.2174/157489106775244109

DO - 10.2174/157489106775244109

M3 - Article

C2 - 18221136

AN - SCOPUS:33748933537

VL - 1

SP - 75

EP - 84

JO - Recent Patents on Anti-Infective Drug Discovery

JF - Recent Patents on Anti-Infective Drug Discovery

SN - 1574-891X

IS - 1

ER -